Daily as of 2 Nov 16:00 ET
- Price
- below both $3.70 vs 50 $4.46 / 200 $4.19
- Projection
- 💀Death cross projected in 15 bars
- Test
- No active test
- Last cross
- No cross on record
IRD | Opus GeneticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$3.70
+$0.03 (+0.82%)
Opus Genetics (IRD) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2026.
Right now the daily is the chart to watch. The 50 SMA sits above the 200, but the two have been closing on each other and a death cross is projected within 20 bars. Price sits below the 50 and the 200 on the daily and the 4-hour.
Timeframe summary
Weekly
No weekly data
4-hour as of 3 Nov 16:00 ET
- Price
- below both $3.93 vs 50 $4.08 / 200 $4.10
- Projection
- No cross projected
- Test
- Cross test window open, no test bar yet
- Last cross
- 💀Death cross 3 Nov 2026 · projected 27 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 3 Nov 2026 | 💀Death | 4-hour | 27 bars out | Active Cross Test |
| 14 Sep 2026 | 🟨Golden | 4-hour | 25 bars out | Not tested |
About IRD
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$5.9M
4-hour coverageYes, since Oct 2025
History on recordSince 2026
SectorHealthcare
Cap bandsmall